Independent Portfolio Consultants’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$13K Sell
65
-235
-78% -$46.8K 0.01% 663
2017
Q1
$55K Sell
300
-105
-26% -$18.3K 0.02% 547
2016
Q4
$65K Buy
405
+15
+4% +$2.2K 0.02% 506
2016
Q3
$55K Sell
390
-150
-28% -$20.9K 0.02% 523
2016
Q2
$74K Hold
540
0.02% 494
2016
Q1
$73K Sell
540
-140
-21% -$18.9K 0.02% 516
2015
Q4
$102K Sell
680
-50
-7% -$7.39K 0.03% 465
2015
Q3
$97K Sell
730
-90
-11% -$12.6K 0.02% 463
2015
Q2
$108K Sell
820
-5
-0.6% -$619 0.02% 489
2015
Q1
$99K Sell
825
-25
-3% -$2.77K 0.02% 481
2014
Q4
$90K Sell
850
-3,475
-80% -$367K 0.02% 530
2014
Q3
$445K Sell
4,325
-805
-16% -$81.6K 0.12% 249
2014
Q2
$481K Buy
5,130
+235
+5% +$20.8K 0.13% 244
2014
Q1
$437K Buy
4,895
+85
+2% +$6.92K 0.14% 275
2013
Q4
$369K Buy
4,810
+1,140
+31% +$84.1K 0.13% 323
2013
Q3
$262K Buy
3,670
+130
+4% +$9.25K 0.1% 385
2013
Q2
$256K Buy
+3,540
New +$260K 0.11% 372

Other funds holding CHE

Independent Portfolio Consultants's CHE Position: Q2 2017 in Review

Independent Portfolio Consultants reduced its Chemed (CHE) stake by 78% in Q2 2017, selling an estimated $46.8K and leaving 65 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #663.

Independent Portfolio Consultants first reported a position in CHE in Q2 2013 and has held it in 17 quarters since. The position peaked at $481K in Q2 2014. 272 funds tracked by Wall St. Rank hold CHE as of Q2 2017.

  • Independent Portfolio Consultants held 65 shares of Chemed worth $13K as of Q2 2017.
  • Independent Portfolio Consultants sold 235 Chemed shares in Q2 2017, an estimated $46.8K.
  • Chemed made up 0.01% of Independent Portfolio Consultants's portfolio in Q2 2017, its #663 holding.
  • Independent Portfolio Consultants first reported a position in Chemed in Q2 2013 and has held it in 17 quarters since.
  • Independent Portfolio Consultants's Chemed position peaked at $481K in Q2 2014.
  • 272 funds tracked by Wall St. Rank held Chemed as of Q2 2017.

Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.